HXHongzhi Xu

Hongzhi Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongzhi Xu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Aili Zhang

    School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China

    1 shared publication
  • Bo Cao

    School of Biomedical Engineering, Shanghai Jiao Tong University, No. 1954, Huashan Road, Xuhui District, Shanghai, China, Shanghai, 200030, China

    1 shared publication
  • Hongying Wang

    School of Biomedical Engineering, Shanghai Jiao Tong University, No. 1954, Huashan Road, Xuhui District, Shanghai, China, Shanghai, Shanghai, 200030, China

    1 shared publication
  • Linyang Wei

    School of Biomedical Engineering, Shanghai Jiao Tong University, No. 1954, Huashan Road, Xuhui District, Shanghai, China, Shanghai, Shanghai, 200030, China

    1 shared publication
  • Ming Xu

    Department of Anaesthesiology, Huashan Hospital Fudan University, No. 12, Middle Wulumuqi Road, Jing'an District, Shanghai, China, Shanghai, Shanghai, 200040, China

    1 shared publication
  • Shiqing Zhao

    School of Biomedical Engineering, 400 Med-X Research Institute, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai 200030, China

    1 shared publication

Latest Publications

  • Electrothermal decoupling for investigating tumor treating fields of glioblastoma

    by Bo Cao, Linyang Wei, Wenhao Zhu, Hongying Wang, Ming Xu, Shiqing Zhao, Hongzhi Xu, Aili Zhang

    Objective: Tumor Treating Fields (TTFields), a non-invasive cancer therapy employing low-intensity alternating electric fields to inhibit cancer cell division, has been used to treat glioblastoma. While clinically established for glioblastoma, the biological contribution of the intrinsic mild hyperthermia (iMH) remains not fully elucidated, limiting mechanistic clarity and treatment optimization. Approach: This study presents a precision in vitro platform designed to decouple the electrical and thermal components of TTFields (230 kHz, 2 V/cm). Based on numerical simulations, the platform utilizes a defined monitoring area to ensure field uniformity and an active thermodynamic compensation protocol to isolate electric and thermal modalities. Main results: Results indicated that the electric field primarily inhibited cell proliferation (32.0% reduction) and migration, whereas the iMH was the primary mediator of cytotoxicity and apoptosis. Notably, the combined electrothermal treatment exhibited a synergistic anti-tumor effect exceeding the additive effects of individual modalities. Significance: These findings suggest that the iMH component of TTFields functions as a therapeutic sensitizer rather than a side effect, offering a basis for optimizing future GBM treatment strategies.